NovoCure
$115.629876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$115.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$3.88 (-3.25%) As of 10:06 AM EDT today
Why Robinhood?
You can buy or sell NovoCure and other stocks, options, and ETFs commission-free!
About NVCR
NovoCure Limited Ordinary Shares, also called NovoCure, is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Read More Helier, Jersey. The listed name for NVCR is NovoCure Limited Ordinary Shares.
Employees
782
Headquarters
St. Helier, Jersey
Founded
2000
Market Cap
11.84B
Price-Earnings Ratio
1.11K
Dividend Yield
—
Average Volume
1.03M
High Today
$118.06
Low Today
$114.28
Open Price
$117.99
Volume
133.98K
52 Week High
$140.89
52 Week Low
$53.40
Collections
Analyst Ratings
33%
of 9 ratings
Buy
33%
Hold
56%
Sell
11%
NVCR Earnings
-$0.14
$0.04
$0.22
$0.40
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
$0.40 per share
Actual
Available Oct 29, Pre-Market